MDXG CIK: 1376339

MiMedx Group, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
202
FY22:
220
FY23:
267
FY24:
289
FY25:
346
(positive)
Change from FY21 to FY25
millions USD
FY21:
−7.05
FY22:
−14.7
FY23:
37.1
FY24:
58.9
FY25:
63.9
(positive)
millions USD
FY21:
–
FY22:
–
FY23:
–
FY24:
–
FY25:
78.8
(positive)
Change from FY21 to FY25
millions USD
FY21:
−12.1
FY22:
−19.7
FY23:
30.6
FY24:
57.3
FY25:
66.3
(positive)
Change from FY21 to FY25
millions USD
FY21:
−10.3
FY22:
−30.2
FY23:
58.2
FY24:
42.4
FY25:
48.6

All amounts in millions USD Data sources:SEC EDGARTwelve Data